Hera News & Events

­

Fine Need Aspirate Serial Tumor Sampling Services to Boost Your Xenograft Study Capabilities

Xenograft tumors from human cancer cell lines in immunocompromised mice are [...]

Validation of the SRG Rat for Human Tumor Studies Published in PLOS ONE

We are excited to announce that a validation study using [...]

Gene Editing With piggyBac: Creating A Curative Treatment For Beta-Thalassemia

Genetic engineering can soon lead to lifelong cures for diseases [...]

OncoRat® featured in Clinical Cancer Research for prostate cancer studies

Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems: A case [...]

The OncoRat® is the ideal host for patient-derived xenografts of ovarian cancer cells

Ovarian cancer is the most lethal gynecological cancer in the [...]

Evolution of the rat model

Rats have been favored for drug development studies because the [...]

H358 NSCLC xenografts in humanized rats: the ideal in vivo model for studying KRAS mutations

Lung adenocarcinomas, the major histological subtype of non-small cell lung [...]

Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research

Hera Biolabs, the University of Michigan, Case Western Reverse University [...]

Breakthroughs in gene editing allows for the creation of superior preclinical oncology models

Gene editing is getting a lot of attention in the [...]

The OncoRat®: Hosting valuable tumor xenograft models that are difficult or impossible to study using in vitro or mouse models

One of the most widely used methods of modeling human [...]